Investor Alert

New York Markets Close in:

Company Close Updates

Aug. 11, 2022, 4:31 p.m. EDT

Moderna Inc. stock underperforms Thursday when compared to competitors

MarketWatch Automation

Shares of Moderna Inc. (NAS:MRNA) slid 1.41% to $171.81 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average (DOW:DJIA) rising 0.08% to 33,336.67 and the NASDAQ Composite Index (NASDAQ:COMP) falling 0.58% to 12,779.91. Moderna Inc. closed $293.04 short of its 52-week high ($464.85), which the company reached on September 10th.

The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as AbbVie Inc. (NYS:ABBV) rose 0.81% to $142.08, Amgen Inc. (NAS:AMGN) fell 1.48% to $248.35, and AstraZeneca PLC ADR (NAS:AZN) fell 1.81% to $64.65. Trading volume (3.3 M) remained 1.8 million below its 50-day average volume of 5.2 M.

Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.

Link to MarketWatch's Slice.